Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
4.49
-0.08 (-1.75%)
At close: May 01, 2025, 3:59 PM
4.50
0.29%
After-hours: May 01, 2025, 07:06 PM EDT
Xeris Biopharma Revenue
Xeris Biopharma reported an annual revenue of $203.07M, reflecting a 23.89% growth. For the quarter ending December 31, 2024, Xeris Biopharma generated $60.1M in revenue.
Revenue (ttm)
$203.07M
Revenue Growth
23.89%
Price / Sales Ratio
2.45
Revenue / Employee
$515.41K
Employees
394
Market Cap
690.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 203.07M | +23.89% |
| Dec 31, 2023 | 163.91M | +48.68% |
| Dec 31, 2022 | 110.25M | n/a |
| Dec 31, 2021 | 110.25M | +122.32% |
| Dec 31, 2020 | 49.59M | n/a |